A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)

Condition:   Primary Biliary Cirrhosis Interventions:   Drug: TQA3526;   Drug: Placebo to match TQA3526 Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials